Genomic Vision (GV.PA) Stock Income Statement
Europe - Euronext Paris - EPA:GV - FR0011799907 - Common Stock
0.0018 EUR
+0 (+5.88%)
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.11M | 1.03M | 994.00K | 1.08M | 1.77M | |||
| Cost Of Goods | 4.54M | 2.72M | 2.22M | 2.26M | 3.55M | |||
| Gross Profit | -3.44M | -1.69M | -1.22M | -1.18M | -1.78M | |||
| Operating Expenses | 5.31M | 4.43M | 3.67M | 4.20M | 2.87M | |||
| Research and Development | 2.02M | 1.96M | 2.12M | 1.48M | 1.53M | |||
| Selling, General, and Administrative Expenses | 1.61M | 1.88M | 1.48M | 1.78M | 1.44M | |||
| Operating Income | -8.74M | -6.12M | -4.89M | -5.38M | -4.65M | |||
| Interest Income/Expense | -1.90M | -668.00K | -67.00K | -24.00K | -1.00K | |||
| Other Income/Expense | -15.00K | N/A | 1.00K | N/A | -2.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 224.00K | 44.00K | |||
| Income Before Taxes | -10.64M | -6.79M | -4.96M | -5.18M | -4.61M | |||
| Income Tax | N/A | N/A | 37.00K | N/A | N/A | |||
| Net Income | -10.62M | -6.79M | -5.00M | -5.18M | -4.61M | |||
| EBITDA | -7.51M | -5.44M | -4.66M | -4.79M | -4.57M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.11 | -0.10 | -0.10 | -0.11 | -0.16 | |||
| Statistics | ||||||||
| Gross Profit Margin | -310.11% | -165.01% | -122.94% | -108.76% | -100.56% | |||
| Profit Margin | -958.66% | -661.79% | -502.82% | -477.58% | -260.34% | |||
| Operating Profit Margin | -788.99% | -596.69% | -492.45% | -496.03% | -262.66% | |||
All data in EUR